Effects of Daidzin and analogue of Ganoderma sinense on bacterially-expressed human hexokinase isoform 2 for anti-dengue drug design
Dengue disease, which is caused by dengue virus (DENV) has been a major worldwide concern, with increased number of cases each year. Currently, there are no specific medications to treat the disease. Hence, there is a dire need to develop novel drugs for disease treatment. Glycolysis is a metabolic...
保存先:
主要な著者: | Asman, Nur Atikah, Tanbin, Suriyea, Ahmad Fuad, Fazia Adyani |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
IIUM Press
2020
|
主題: | |
オンライン・アクセス: | http://irep.iium.edu.my/87086/1/87086_effects%20off%20daidzin%20and%20analogue%20off%20ganoderma%20sinensetin_ft.pdf http://irep.iium.edu.my/87086/ https://journals.iium.edu.my/bnrej/index.php/bnrej/article/view/48 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Novel compounds as potential anti-dengue therapies verified via inhibition of human hexokinase isoform II
著者:: Tanbin, Suriyea, 等
出版事項: (2020) -
Elucidating the analogues of 3-bromopyruvate (3-BP) as inhibitors against human hexokinase II for the development of anti-dengue drugs
著者:: Tanbin, Suriyea, 等
出版事項: (2019) -
Enhanced expression and purification strategy for recombinant bacterially-expressed human hexokinase II
著者:: Ahmad Fuad, Fazia Adyani, 等
出版事項: (2021) -
Expression and purification of soluble bacterially-expressed human hexokinase II in E.coli system
著者:: Tanbin, Suriyea, 等
出版事項: (2019) -
Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII)
著者:: Ahmad Fuad, Fazia Adyani, 等
出版事項: (2020)